Status Epilepticus After Massive Carbamazepine Overdose

REFERENCES

• Spiller H.A., Krenzelok E., Cooksan E. Carbamazepine Overdose: A Prospective Study of Serums and Toxicity. J. Toxicol. Clin. Toxicol. 1990; 28: 433–444
   PubMedGoogle Scholar
• Durelli L., Massazza U., Cavallo R. Carbamazepine Toxicity and Poisoning. Incidence, Clinical Features and Management. Med. Toxicol. Adv. Drug. Exp. 1989; 4: 94–107
   Google Scholar
• Weaver D.F., Camfield P., Fraser A. Massive Carbamazepine Overdose: Clinical and Pharmacologic Observations in Five Episodes. Neurology 1988; 38: 755–759
   PubMed Web of Science ®Google Scholar
• Denning D.W., Matheson L., Bryson S.M., Streete J., Berry D.J., Henry J.A. Death Due to Carbamazepine Self-Poisoning: Remedies Reviewed. Hum. Toxicol. 1985; 4: 255–260
   PubMedGoogle Scholar
• Stremski E.S., Brady W.B., Prasad K., Hennes H.A. Pediatric Carbamazepine Intoxication. Ann. Emerg. Med. 1995; 25: 624–630
   PubMed Web of Science ®Google Scholar
• Schmidt S., Schmitz-Buhl M. Signs and Symptoms of Carbamazepine Overdose. J. Neurol. 1995; 242: 169–173
   PubMed Web of Science ®Google Scholar
• Hojer J., Malmlund H.O., Berg A. Clinical Features in 28 Consecutive Cases of Laboratory Confirmed Massive Poisoning with Carbamazepine Alone. J. Toxicol. Clin. Toxicol. 1993; 31: 449–458
   PubMed Web of Science ®Google Scholar
• Catterall W.A. Molecular Properties of Brain Sodium Channels: An Important Target for Anticonvulsant Drugs. Adv. Neurol. 1999; 79: 441–456
   PubMedGoogle Scholar
• Lingamaneni R., Hemmings H.C. Effects of Anticonvulsants on Veratridine and KCL Evoked Glutamate Release from Rat Cortical Synaptosomes. Neurosci. Lett. 1999; 276: 127–130
   PubMed Web of Science ®Google Scholar
• Yoshimura R., Yanagihara N., Terao T., Minami K., Abe K., Izumi F. Inhibition by Carbamazepine of Various Ion Channels Mediated Catecholamine Secretion in Cultured Bovine Adrenal Medullary Cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 1995; 352: 297–303
   Google Scholar
• Skerritt J.H., Davies L.P., Johnston G.A. Interactions of the Anticonvulsant Carbamazepine with Adenosine Receptors. Epilesia 1983; 24: 634–642
   PubMed Web of Science ®Google Scholar
• Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the Effects of Caffeine and Carbamazepine on the Striatal Dopamine Release by In Vivo Microdialysis. Eur. J. Pharmacol. 1997; 321: 181–188
   PubMed Web of Science ®Google Scholar
• Lampe H., Bigalke H. Carbamazepine Blocks NMDA-Activated Currents in Cultured Spinal Cord Neurons. Neuroreport 1990; 1: 26–28
   PubMedGoogle Scholar
• Zaidat O.O., Kaminski H.J., Berenson F., Katirji B. Neuromuscular Transmission Defect Caused by Carbamazepine. Muscle Nerve 1999; 22: 1293–1296
   PubMed Web of Science ®Google Scholar
• Fujiwara Y., Sato M., Otsuki S. Interaction of Carbamazepine and Other Drugs with Adenosine (A1 and A2) Receptors. Psychopharmacology 1986; 90: 332–335
   PubMed Web of Science ®Google Scholar
• Van Calker D., Steber R., Klotz K.N., Greil W. Carbamazepine Distinguishes Between Adenosine Receptors That Mediate Different Second Messenger Responses. Eur. J. Pharmacol. 1991; 206: 285–290
   PubMed Web of Science ®Google Scholar
• Zanagrossi H., Leite J.R., Graeff F.G. Anxiolytic Effect of Carbamazepine in the Elevated Plus-Maze: Possible Role of Adenosine. Psychopharmacology 1992; 106: 85–89
   PubMed Web of Science ®Google Scholar
• Schneck H.J., Rupreht J. Central Anticholinergic Syndrome in Anesthesia and Intensive Care. Acta Anaesthesiol. Belg. 1989; 40: 219–228
   PubMedGoogle Scholar
• Brunner G.A., Fleck S., Peiber T.R., Lueger A., Kaufmann P., Smolle K.H., Brussee H., Krejs G.J. Near Fatal Anticholinergic Intoxication After Routine Fundoscopy. Intensive Care Med. 1998; 24: 730–731
   PubMed Web of Science ®Google Scholar
• Danze L.K., Langdorf M.I. Reversal of Orphenadrine-Induced Ventricular Tachycardia with Physostigmine. J. Emerg. Med. 1991; 9: 453–457
   PubMedGoogle Scholar
• Picard F., Bertrand S., Steinlein O.K., Bertrand D. Mutated Nicotinic Receptors Responsible for Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Are More Sensitive to Carbamazepine. Epilepsia 1999; 40: 1198–1209
   PubMed Web of Science ®Google Scholar
• Eldridge F.L., Paydafar D., Scott S.C., Dowell R.T. Role of Endogenous Adenosine in Recurrent Generalized Seizures. Exp. Neurol. 1989; 103: 179–185
   PubMed Web of Science ®Google Scholar
• Dodd P.R., Watson W.E., Johnson G.A. Adenosine Receptors in Post Mortem Human Cerebral Cortex and the Effect of Carbamazepine. Clin. Exp. Pharmacol. Physiol. 1986; 13: 711–712
   PubMed Web of Science ®Google Scholar
• Kulkarni C., David J., Joseph T. Influence of Adenosine, Dipyridamole, Adenosine Antagonists and Antiepileptic Drugs on EEG After Discharge Following Cortical Stimulation. Indian J. Exp. Biology 1997; 35: 342–347
   PubMedGoogle Scholar
• Hornfelt C.S., Larson A.A. Adenosine Receptors Are Not Involved in Theophyllien Induced Seizures. J. Toxicol. Clin. Toxicol. 1994; 32: 257–265
   PubMedGoogle Scholar
• Malhotra J., Gupta Y.K. Effect of Adenosinergic Modulation of the Anticonvulsant Effect of Phenobarbitone and Carbamazepine. Methods Find. Exp. Clin. Pharmacol. 1999; 21: 79–83
   PubMed Web of Science ®Google Scholar
• Larkin J.G., Thompson G.G., Scobie G., Drennan J.E., Brodie M.J. Lack of Major Effects on Mouse Brain Adenosine A1 Receptors of Oral Carbamazepine and Calcium Antagonists. Epilepsia 1991; 32: 729–734
   PubMed Web of Science ®Google Scholar
• Kumar A., Bleck T.P. Intravenous Midazolam for the Treatment of Refractory Status Epilepticus. Crit. Care Med. 1992; 20: 483–488
   PubMed Web of Science ®Google Scholar
• Parent J.M., Lowenstein D.H. Treatment of Refractory Generalized Status Epilepticus with Continuous Infusion of Midazolam. Neurology 1994; 44: 1837–1840
   PubMed Web of Science ®Google Scholar
• Rivera R., Segnini M., Baltodano A., Perez V. Midazolam in the Treatment of Status Epilepticus in Children. Crit. Care Med. 1993; 21: 991–994
   PubMed Web of Science ®Google Scholar
• Czuczwar S.J., Janusz W., Wamil A., Keinrok Z. Inhibition of Aminophylline-Induced Convulsions in Mice by Antiepileptic Drugs and Other Agents. Eur. J. Pharmacol. 1987; 144(3)309–315
   PubMed Web of Science ®Google Scholar
• Jacobs M.H., Senior R.M., Kessler G. Clinical Experience with Theophylline: Relationships Between Dosage, Serum Concentrations, and Toxicity. J. Am. Med. Assoc. 1976; 235: 1983–1986
   PubMed Web of Science ®Google Scholar
• Stone W.E., Javid M.J. Aminophylline and Imidazole as Convulsants. Arch. Int. Pharmacodyn. Ther. 1980; 248(1)120–131
   PubMedGoogle Scholar
• Kenneback G., Bergfeldt L., Tomson T. Electrophysiological Evaluation of the Sodium Channel Blocker Carbamazepine in Healthy Human Subjects. Cardiovasc. Drugs Ther. 1995; 9: 709–714
   PubMed Web of Science ®Google Scholar
• Leslie P.J., Heyworth R., Prescott L.F. Cardiac Complications of Carbamazepine Intoxication: Treatment by Haemoperfusion. Br. Med. J. 1983; 286(6370)1018
   PubMed Web of Science ®Google Scholar
• Callaham M., Schumaker H., Pentel P. Phenytoin Prophylaxis of Cardiotoxicity in Experimental Amitriptyline Poisoning. J. Exp. Pharmacol. Ther. 1988; 245: 216–220
   PubMed Web of Science ®Google Scholar
• Bertram M., Fabian C.W., Schwarz S., Schwab S. Massive Carbamazepine Overdose: Clinical and Neurophysiological Findings. J. Neurol. 1998; 245: 745–747
   PubMed Web of Science ®Google Scholar
• Nilsson C., Sterner G., Idvall J. Charcoal Hemoperfusion for Serious Carbamazepine Poisoning. Acta Med. Scand. 1984; 216: 137–140
   PubMed Web of Science ®Google Scholar
• de Zeeuw R.A., Westenberg H.G., van der Kleijn E., Gimbrere J.S. An Unusual Case of Carbamazepine Poisoning with a Near-Fatal Relapse After Two Days. J. Toxicol. Clin. Toxicol. 1983; 14(3)263–269
   Google Scholar